Experienced in Gastritis

Dr. Fred B. Rosenberg

Gastroenterology
Regional Gastroenterology Associates Of Lancaster, Ltd.
2112 Harrisburg Pike, Suite 202, 
Lancaster, PA 
Accepting New Patients
Experienced in Gastritis
Regional Gastroenterology Associates Of Lancaster, Ltd.
2112 Harrisburg Pike, Suite 202, 
Lancaster, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Fred Rosenberg is a Gastroenterologist in Lancaster, Pennsylvania. Dr. Rosenberg is rated as an Experienced provider by MediFind in the treatment of Gastritis. His top areas of expertise are Gastroesophageal Reflux Disease (GERD), Gastric Dysmotility, Diarrhea, Gastrectomy, and Endoscopy. Dr. Rosenberg is currently accepting new patients.

His clinical research consists of co-authoring 2 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Gastroenterology
Licenses
Internal Medicine in IL
Languages Spoken
English
Italian
Spanish
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D

Locations

REGIONAL GASTROENTEROLOGY ASSOCIATES OF LANCASTER, LTD.
2112 Harrisburg Pike, Suite 202, Lancaster, PA 17601

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Enrollment Status: Completed
Publish Date: June 21, 2024
Intervention Type: Drug
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
Enrollment Status: Terminated
Publish Date: March 31, 2022
Intervention Type: Drug, Other
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
Enrollment Status: Completed
Publish Date: January 14, 2022
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 306)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 306)
Enrollment Status: Terminated
Publish Date: May 11, 2021
Intervention Type: Other, Biological
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)
Enrollment Status: Terminated
Publish Date: April 26, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials

2 Total Publications

Challenges Facing Independent Integrated Gastroenterology 2017.
Challenges Facing Independent Integrated Gastroenterology 2017.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: February 19, 2017
Similar Doctors
Elite in Gastritis
Dr. Gary W. Falk
Gastroenterology
Elite in Gastritis
Dr. Gary W. Falk
Gastroenterology
3400 Civic Center Blvd, Pcam 4 South, 
Philadelphia, PA 
 (62.0 miles away)
215-349-8222
Languages Spoken:
English
See accepted insurances

Gary Falk is a Gastroenterologist in Philadelphia, Pennsylvania. Dr. Falk is rated as an Elite provider by MediFind in the treatment of Gastritis. His top areas of expertise are Barrett Esophagus, Eosinophilic Esophagitis, Esophagitis, Gastritis, and Endoscopy.

Distinguished in Gastritis
Dr. Amanda B. Muir
Pediatric Gastroenterology | Gastroenterology | Pediatrics
Distinguished in Gastritis
Dr. Amanda B. Muir
Pediatric Gastroenterology | Gastroenterology | Pediatrics
3401 Civic Center Blvd, Children's Hospital Of Philadelphia - Gastroenterology, 
Philadelphia, PA 
 (62.0 miles away)
215-590-3249
Languages Spoken:
English
See accepted insurances

Amanda Muir is a Pediatric Gastroenterologist and a Gastroenterologist in Philadelphia, Pennsylvania. Dr. Muir is rated as a Distinguished provider by MediFind in the treatment of Gastritis. Her top areas of expertise are Esophagitis, Eosinophilic Esophagitis, Viral Gastroenteritis, Eosinophilic Enteropathy, and Endoscopy.

Distinguished in Gastritis
Dr. Amrit Narula
Gastroenterology
Distinguished in Gastritis
Dr. Amrit Narula
Gastroenterology

Integrated Medical Group, P.C.

48 Tunnel Rd, Suite 104, 
Pottsville, PA 
 (45.1 miles away)
570-622-5555
Languages Spoken:
English
See accepted insurances

Amrit Narula is a Gastroenterologist in Pottsville, Pennsylvania. Dr. Narula is rated as a Distinguished provider by MediFind in the treatment of Gastritis. His top areas of expertise are Barrett Esophagus, Diverticular Disease, Colitis, Endoscopy, and Gastrostomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Rosenberg's expertise for a condition
ConditionClose
        View All 46 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile